Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trial
Jie Wu(Chinese University of Hong Kong), Xiangmei Chen(State Administration of Traditional Chinese Medicine of the People's Republic of China), Qiang He(Zhejiang Chinese Medical University), Wei Li(University of California, Irvine), Yin Ai-ping(First Affiliated Hospital of Xi'an Jiaotong University), Zhaohui Ni(Shanghai Jiao Tong University), Zhiyong Guo(Second Military Medical University), Niansong Wang(Shanghai Sixth People's Hospital), Rongshan Li(Shanxi Medical University), Jingai Fang(Shanxi Medical University), Guangyan Cai(Chinese PLA General Hospital), Jifeng Sun(Tang Du Hospital), Ming Chen(Chengdu University of Traditional Chinese Medicine), Gao Ji-ning(Shanxi Province Hospital of Traditional Chinese Medicine), Jian Chen(Hong Kong University of Science and Technology), Lihua Wang(Shanxi Medical University), Ying Lü(Beijing University of Chinese Medicine), Hao Zhang(Central South University), Ying Li(Wuxi People's Hospital), Changying Xing(Nanjing Medical University), Yun Li(University of Groningen), Xusheng Liu(Guangdong Provincial Hospital of Traditional Chinese Medicine), Wenhu Liu(Capital Medical University), Rong Wang(Xi'an University of Science and Technology), Jun Zhu(Jiangnan University), Shan Lin(Tianjin Medical University General Hospital), Meng Liang(174th hospital of the People's Liberation Army), Qiaoling Zhou(Central South University), HE Li-qun(Shanghai University of Traditional Chinese Medicine), Hongtao Yang(First Teaching Hospital of Tianjin University of Traditional Chinese Medicine), Shiren Sun(Xijing Hospital), Yueyi Deng(Shanghai University of Traditional Chinese Medicine), Hongyu Chen(Hangzhou Hospital of Traditional Chinese Medicine), Yani He(PLA Army Engineering University), Yongli Zhan(Chinese Academy of Medical Sciences & Peking Union Medical College), Hongli Lin(Dalian Medical University), Qing Zhu(Henan Provincial People's Hospital), Liqun Song(First Affiliated Hospital of Heilongjiang University of Chinese Medicine), Shuwei Duan(People's Liberation Army No. 150 Hospital), Junzhou Fu(Guangzhou University of Chinese Medicine), Ping Luo(Jiangxi University of Traditional Chinese Medicine), Xiaohong Cheng(Shaanxi Provincial Hospital of Traditional Chinese Medicine), Lu Ma(Brookhaven National Laboratory)
Cited by 6
Related Papers
Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet|2019|3.8k
Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs
|International Journal of Pharmaceutics|2012|559
Highly efficient dye adsorption and removal: a functional hybrid of reduced graphene oxide–Fe3O4 nanoparticles as an easily regenerative adsorbent
|Journal of Materials Chemistry|2012|415
Genetic loci influencing kidney function and chronic kidney disease
|Nature Genetics|2010|269